Iridium;3,5,7-trimethyl-10-phenoxy-12H-imidazo[1,2-f]phenanthridin-12-ide
C24H19IrN2O- — CID 59359067
Data last refreshed: (MolForge compound catalog, from PubChem)
About Iridium;3,5,7-trimethyl-10-phenoxy-12H-imidazo[1,2-f]phenanthridin-12-ide
Iridium;3,5,7-trimethyl-10-phenoxy-12H-imidazo[1,2-f]phenanthridin-12-ide (PubChem CID 59359067) has the molecular formula C24H19IrN2O- and a molecular weight of 543.65 g/mol. Its IUPAC name is iridium;3,5,7-trimethyl-10-phenoxy-12H-imidazo[1,2-f]phenanthridin-12-ide.
Molecular Properties
| Compound Name | Iridium;3,5,7-trimethyl-10-phenoxy-12H-imidazo[1,2-f]phenanthridin-12-ide |
|---|---|
| PubChem CID | 59359067 |
| Molecular Formula | C24H19IrN2O- |
| Molecular Weight | 543.65 g/mol |
| Exact Mass | 544.11 |
| IUPAC Name | iridium;3,5,7-trimethyl-10-phenoxy-12H-imidazo[1,2-f]phenanthridin-12-ide |
| SMILES | Cc1cc(C)c2c(c1)c1cc(Oc3ccccc3)c[c-]c1c1ncc(C)n12.[Ir] |
| InChI | InChI=1S/C24H19N2O.Ir/c1-15-11-16(2)23-22(12-15)21-13-19(27-18-7-5-4-6-8-18)9-10-20(21)24-25-14-17(3)26(23)24;/h4-9,11-14H,1-3H3;/q-1; |
| InChIKey | YXPNMEFXYXAZBT-UHFFFAOYSA-N |
| XLogP | 6.16 |
| TPSA | 26.53 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 543.65 |
| LogP ≤ 5 | 6.16 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 59359067 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.